Hypnosis and self-hypnosis, administered and taught by nurses, for the reduction of chronic pain: a controlled clinical trial

ISRCTN ISRCTN32129167
DOI https://doi.org/10.1186/ISRCTN32129167
Secondary identifying numbers N/A
Submission date
06/09/2005
Registration date
04/10/2005
Last edited
10/09/2009
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Signs and Symptoms
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Bernard Burnand
Scientific

IUMSP
Bugnon 17
Lausanne
CH-1010
Switzerland

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Not specified
Study typeTreatment
Scientific title
Study objectivesHypnosis and auto-hypnosis do not reduce pain in patients with chronic pain
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedVarious conditions engendering chronic pain
InterventionHypnosis and auto-hypnosis administered and taught by trained nurses
Intervention typeOther
Primary outcome measureLevel of pain (VAS)
Secondary outcome measures1. Physical activity (tridimensional accelerometer)
2. Health related quality of life (SF-36)
Overall study start date01/05/1993
Completion date31/12/1994

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexBoth
Target number of participants2 x 65 = 130
Key inclusion criteria1. To be referred (including occasional self-referral) for the management of chronic pain
2. To live within manageable distances from the hospital
3. To be aged 18 or above
4. To understand and speak French adequately
5. To be able to see, hear and communicate (i.e. no alteration of consciousness)
6. To have no diagnosis of mental illness (e.g. psychosis)
7. To give informed consent
Key exclusion criteriaPatients were excluded from the study whenever they wished and/or when no conventional treatment could be proposed.
Date of first enrolment01/05/1993
Date of final enrolment31/12/1994

Locations

Countries of recruitment

  • Switzerland

Study participating centre

IUMSP
Lausanne
CH-1010
Switzerland

Sponsor information

Hospital of Morges (Switzerland)
Hospital/treatment centre

Morges
CH-1110
Switzerland

ROR logo "ROR" https://ror.org/026qe1m81

Funders

Funder type

Government

Swiss National Science Foundation (Switzerland) (SNF 4034-35883)
Private sector organisation / Trusts, charities, foundations (both public and private)
Alternative name(s)
Schweizerischer Nationalfonds, Swiss National Science Foundation, Fonds National Suisse de la Recherche Scientifique, Fondo Nazionale Svizzero per la Ricerca Scientifica, Fonds National Suisse, Fondo Nazionale Svizzero, Schweizerische Nationalfonds, SNF, SNSF, FNS
Location
Switzerland

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Protocol article protocol 01/08/1994 Yes No